ea0056p806 | Pituitary - Clinical | ECE2018
Kim Daham
, Lee Youngki
, Park Se Hee
, Park Kyeong Hye
, Ryong Ku Cheol
, Kim Sun Ho
, Lee Eun Jig
Objectives: Prolactin (PRL) normalization after 3 months of Cabergoline (CAB) treatment are useful predictors of responsiveness in patients with prolactinoma. However, differences within the PRL normalization cut-off value have not been identified.Methods: We reviewed the medical records of patients with prolactinomas who were treated with CAB as a primary drug at Severance Hospital. We included patients who had a full dataset of pituitary hormone assays...